Answers are grounded in this paper and cite their sources.
Introduction: Keloids are benign fibroproliferative scars characterized by excessive collagen deposition, frequently associated with pain, pruritus, cosmetic disfigurement, and high recurrence rates. Intralesional triamcinolone acetonide (TAC) remains the standard treatment, while cryotherapy has been proposed as an adjunct to enhance therapeutic outcomes. Objective: To evaluate the efficacy and safety of intralesional TAC alone versus cryotherapy combined with intralesional TAC in patients with keloids. Methods: Fifty patients were randomly allotted to two groups (25 each): Group 1 received monthly intralesional TAC injections, while Group 2 received cryotherapy followed by intralesional TAC. Treatment outcomes were assessed using the Vancouver Scar Scale (VSS), scar height, vascularity, pigmentation, pliability, pain, and pruritus. Results: Both groups demonstrated significant improvement in all clinical parameters throughout follow-up. Mean VSS scores decreased from 9.76 ± 0.83 to 0.28 ± 0.61 in the TAC group and from 10.08 ± 1.22 to 0.16 ± 0.47 in the combination group. Complete resolution of pain and pruritus was achieved in all patients by four weeks. Although combination therapy showed a trend toward earlier improvement in selected scar characteristics, overall efficacy was comparable between groups. The pattern of complications differed, but adverse events were infrequent. Conclusion: Intralesional TAC alone remains an effective, simple, and well-tolerated treatment for keloids, while adjunctive cryotherapy may be considered in selected patients based on lesion characteristics and individual risk profiles.
No takes yet. Share an insight, caveat, or question.
Harsh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: